Core Insights - Yinos's stock price dropped by 4.30% on September 26, with a trading volume of 68.4983 million yuan [1] - The company reported a financing net buy of -1.9928 million yuan on the same day, indicating more repayments than new purchases [1] - As of September 26, the total margin balance for Yinos was 73.0346 million yuan, which is 1.70% of its market capitalization, reflecting a low financing level compared to the past year [1] Financial Performance - For the first half of 2025, Yinos achieved operating revenue of 375 million yuan, a year-on-year decrease of 38.04% [2] - The net profit attributable to the parent company was -15.1895 million yuan, a significant decline of 115.88% compared to the previous period [2] Shareholder and Institutional Holdings - As of June 30, 2025, the number of Yinos shareholders was 5,386, a decrease of 0.90% from the previous period [2] - The top ten circulating shareholders include ICBC Medical Health Stock, which increased its holdings by 72,300 shares to 439,400 shares [3] - New institutional shareholders include ICBC Strategic Transformation Stock and Harvest Medical Health Stock, which entered the top ten list [3]
益诺思9月26日获融资买入329.85万元，融资余额7303.46万元